Document And Entity Information
Document And Entity Information | Nov. 07, 2023 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 07, 2023 |
Entity Registrant Name | Fulcrum Therapeutics, Inc. |
Entity Central Index Key | 0001680581 |
Entity Emerging Growth Company | true |
Securities Act File Number | 001-38978 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-4839948 |
Entity Address, Address Line One | 26 Landsdowne Street |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02139 |
City Area Code | (617) |
Local Phone Number | 651-8851 |
Entity Information, Former Legal or Registered Name | N/A |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Common stock, par value $0.001 per share |
Trading Symbol | FULC |
Security Exchange Name | NASDAQ |